Amgen to acquire biopharma firm ChemoCentryx for $3.7bn
The board of directors of Amgen and ChemoCentryx has granted unanimous approval for the acquisition.
Autoimmune Disorders
Latest in
Autoimmune Disorders
Gilead Sciences signs agreement to acquire MiroBio for $405m
Gilead will gain access to the discovery platform and complete line of the immune inhibitory receptor agonists of MiroBio.
US FDA grants approval for Janssen’s Stelara to treat psoriatic arthritis
A completely human monoclonal antibody, Stelara hinders cytokines IL-12 and IL-23.
US FDA grants approval to Incyte’s Opzelura cream for vitiligo treatment
The approval was based on findings from Phase III TRuE-V clinical trial programme of Opzelura in nonsegmental vitiligo patients.
Pierre Fabre and Lonza sign antibody manufacturing agreement
W0180 is presently being analysed in a Phase I clinical trial for various solid tumours.
AstraZeneca’s Saphnelo gets approval in the EU for SLE
The approval is based on data from the clinical development programme of Saphnelo, including the TULIP and MUSE trials.
China grants approval to GSK’s Benlysta for lupus nephritis treatment
The approval is based on findings from the Phase III BLISS-LN clinical trial of belimumab in adults with active LN.
More treatment options are needed for paediatric eosinophilic esophagitis
There are currently no late-stage pipeline agents for eosinophilic esophagitis being studied in paediatric populations.
By